← Open Payments lookup

JULIE ERPS: Open Payments

NPI 1992849236 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,902 in 82 payments from 14 companies in 2025. Trend: 2023 $940 · 2024 $1,313 · 2025 $1,902

Food & beverage: $1,902
CompanyPaymentsAmount
ABBVIE INC.30$549
Madrigal Pharmaceuticals11$290
Takeda Pharmaceuticals U.S.A., Inc.10$271
Novo Nordisk Inc3$150
Gilead Sciences, Inc.6$142
VIVUS LLC5$117
PFIZER INC.5$110
Aimmune Therapeutics, Inc.4$86
Janssen Biotech, Inc.2$50
Celltrion USA Inc.2$45

Products named: REZDIFFRA, ENTYVIO, RINVOQ, SKYRIZI, Wegovy, PANCREAZE, CREON, ZENPEP.

Industry payments across TX — which companies pay providers there.